Article
RET receptor signaling: Function in development, metabolic disease, and cancer
10 Mar 2022
Abstract excerpt
The RET proto-oncogene encodes a receptor tyrosine kinase whose alterations are responsible for various human cancers and developmental disorders, including thyroid cancer, non-small cell lung cancer, multiple endocrine neoplasia type 2, and Hirschsprung's disease. RET receptors are physiologically activated by glial cell line-derived neurotrophic factor (GDNF) family ligands that bind to the coreceptor GDNF...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
